Artificial Heart 3

I Overview, Artificial Heart Programme.- 1. An overview of the National Heart, Lung, and Blood Institute Artificial Heart Program.- II Biomaterial for Artificial Heart.- 2. Blood compatibility of bioactive polyurethane surfaces.- 3. Evaluation of cytoplasmic free calcium levels in platelets interacting with polymer surfaces.- 4. Blood-compatibility by surface-grafting with polymerizable anticoagulants.- 5. Activation of platelets on well-defined microdomain structures.- 6. Human blood protein and cell interactions with cardiovascular materials.- 7. Retrieval analyses of U-100 Total Artificial Heart blood-contacting surface.- 8. Novel photoreactive surface process technology for fabricated devices.- 9. Effect of polyol chemistry on the in vitro biostability of segmented polyurethanes.- III Pump Design of Artificial Heart.- 10. An electromagnetically driven univalved artificial heart.- 11. Experimental study of nutating centrifugal blood pump in vivo.- 12. Development of artificial heart with left and right ventricles using a linear pulse motor.- 13. Preliminary study - Optimization of spiral vortex blood pump.- 14. Valvo-pump: Axial nonpulsatile blood pump implanted at the heart valve position.- 15. Muscle-powered cardiac assist device (MCAD) for right ventricular support: Current status and future directions.- 16. Pendulum swing artificial heart.- 17. Development of an artificial heart actuator for a compliance chamberless blood pump.- IV Implantable Artificial Heart.- 18. Toward a totally implantable artificial heart: Development status at Cleveland Clinic.- 19. Completely implantable total artificial hearts: Status at the Texas Heart Institute.- 20. Self-regulation of an electrohydraulic total artificial heart.- 21. Motor-driven, computer-controlled implantable cardiac assist device - An optical encoder for feedback control.- 22. The prospective control of a total artificial heart using sympathetic tone and hemodynamic parameters.- 23. Development of a totally implantable electric assist pump system.- 24. The Penn State implantable artificial heart: Current status.- 25. Development of a better fit total artificial heart based on magnetic resonance imaging anatomical study.- 26. Tomasu heart in goat: Analysis of cause of death.- 27. Design of moving-actuator total artificial heart (Korean heart).- 28. Simplified right-left balance for the implanted artificial heart.- V Heart Transplantation.- 29. Cardiac transplantation in the United States of America.- 30. Cardiac transplantation: Australian results.- 31. Heart transplantation - Status in Europe.- 32. Heart and lung preservation using a new solution: UCLA Formula.- 33. Early graft failure after heart transplantation: Circulatory assist versus retransplantation.- 34. Heterotopic heart transplantation for selected high-risk patients.- VI Bridge Use of Artificial Heart.- 35. Bridging to cardiac transplantation with circulatory support devices.- 36. Bridge to transplantation indications for Symbion TAH, Symbion AVAD, and Novacor LVAS.- 37. Univentricular support in a bridge-to-transplant experience.- 38. Use of ventricular assist device (VAD) in patient with end-stage valvular heart disease.- 39. Postcardiotomy patients treated with mechanical circulatory support: Potential candidates for a bridge to transplantation.- 40. A new bridging technique to heart transplantation in patients with ventricular septal perforation and mitral regurgitation after acute myocardial infarction - Feasibility of monoventricularization of bilateral ventricles with LVAD.- Scientific Exhibition.- Key Word Index.